Results 281 to 290 of about 99,964 (316)
Some of the next articles are maybe not open access.
Complications of intravitreal injections
Current Opinion in Ophthalmology, 2010Over the past few years, the results of many studies have highlighted the risks and benefits of intravitreal injection of a number of medications, the most common being triamcinolone, antivascular endothelial growth factor (VEGF) agents, antibiotics, antivirals, antifungals, and methotrexate. The purpose of this review is to highlight the complications
Sampat, Kapil M., Garg, Sunir J.
openaire +2 more sources
Corticosteroid Intravitreal Implants
2012Intraocular implants developed for ocular inflammation which release glucocorticoids for a prolonged period within the vitreous cavity make use of either a bioerodible polymer (dexamethasone in polylactic acid-coglycolic acid matrix) or non-erodible implantable device (fluocinolone acetonide, FA, in a polyvinyl acetate/silicone laminate ...
openaire +2 more sources
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Ophthalmology (Rochester, Minn.), 2012J. Heier +19 more
semanticscholar +1 more source
Intravitreal Methotrexate for Retinoblastoma
Ophthalmology, 2011Paloheimo Markku +5 more
openaire +2 more sources
Intravitreal Triamcinolone Acetonide
Retina, 2004Gholam A, Peyman, Darius M, Moshfeghi
openaire +2 more sources

